Navigation Links
3SBio Inc. Schedules Unaudited First Quarter 2011 Results
Date:5/3/2011

SHENYANG, China, May 3, 2011 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it will release its first quarter 2011 unaudited financial results after the NASDAQ stock market  closes on Wednesday, May 11, 2011 at 8:00pm (US Eastern ).

Following the earnings announcement, 3SBio's senior management will host a conference call at 5:00am (US Pacific) / 8:00am (US Eastern) / 8:00pm (Beijing) on Thursday, May 12, 2011 to discuss its first quarter 2011  unaudited financial results and recent business activity. The conference call may be accessed using the dial-in numbers below:

Conference ID: 64963899

Local dial-in:China landline  

800-819-0121China mobile

400-620-8038Hong Kong  

852-2475-0994International toll-free dial-in:Hong Kong

800930346United Kingdom  

080-8234-6646United States  

1-866-519-4004International toll dial-in: 65 6723 9381

Replay- Conference ID: 64963899

A telephone replay will be available two hours after the call until May 19, 2011 at:

International dial-in:

61-2-8235-5000United States dial-in:

1-866-214-5335WebcastA live webcast of the conference will be available on the investor relations page of 3SBio's website at http://bbs.3sbio.com/en/News/xinvestors.aspx and at http://tinyurl.com/3SBio2011Q1

A replay of the webcast will be available within one hour after the conclusion of the call.

About 3SBio Inc.3SBio is a leading, fully integrated, profitable biotechnology company focused on researching, develop
'/>"/>

SOURCE 3SBio Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. 3SBio Inc. Announces Second Quarter 2008 Results
2. 3SBio Inc. to Hold Annual General Meeting
3. 3SBio Inc. to Present at the Morgan Stanley Global Healthcare Unplugged Conference
4. 3SBio Inc. Announces Results of Annual General Meeting
5. 3SBio Inc. to Present at the UBS Global Life Sciences Conference
6. 3SBio Inc. Files for SFDA Approval of High-dose (36,000 IU) EPIAO
7. 3SBio Inc. Schedules 2008 Third Quarter Earnings Release on Monday, November 10, 2008
8. 3SBio Inc. Announces Preliminary Third Quarter 2008 Results
9. 3SBio Inc. Files for SFDA Approval of NuLeusin
10. 3SBio Inc. Announces Third Quarter 2008 Results
11. 3SBio Inc. to Present at the Piper Jaffray 20th Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... DTS Language Services, Inc . is pleased to announce ... organizations who need document translations. Clients will now have ... in advance with a selection of nearly 50 life science ... critical factor in clinical and scientific fields, and decrease the ...
(Date:1/15/2014)... CA (PRWEB) January 15, 2014 ... research solutions, today announced that Lupin Limited, one of ... Freeslate’s CM Protégé PharmD System for high ... Mumbai, India, is focused on a wide range of ...
(Date:1/15/2014)... 2014 TaiGen Biotechnology Company, Limited ("TaiGen") today announced ... a leading Russian pharmaceutical company, to develop and commercialize ... Federation , Turkey and ... a novel antibiotic for the treatment of bacterial infections ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 Carahsoft and ... Thursday, January 23, 2014 at 2pm EST (11am PST), ... The topic focuses on how technology can turn raw, ... decisions for government agencies. The online webinar will last ...
Breaking Biology Technology:DTS Improves Efficiency for Life Science Document Translations 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge – Hosted by Carahsoft and CDS Federal Services 2
... ... today a strategic agreement with leading contract services company Novation, to ... nearly 14,000 members of Provista, LLC with the only automated pharmaceutical ... hospitals and systems, academic medical centers, ambulatory care and physician clinics, ...
... , , , ... that it has received 510K Clearance from the FDA for ... deliver the device in the United States. Aixplorer is ... Technology, which is based upon interaction between conventional longitudinal waves ...
... , , , NEW ... Wolmer) filed suit yesterday against Celgene Corporation (Nasdaq: ... and "unjust enrichment" regarding the Company,s sale of thalidomide (THALOMID(R) ... suit alleges that Ms. Jacobson developed the original and novel ...
Cached Biology Technology:Vestara Announces Strategic Agreement with Leading Contract Services Company Novation 2SuperSonic Imagine Receives FDA Approval for Aixplorer Ultrasound System 2SuperSonic Imagine Receives FDA Approval for Aixplorer Ultrasound System 3SuperSonic Imagine Receives FDA Approval for Aixplorer Ultrasound System 4
(Date:4/17/2014)... . Our eyes ... us with a continuous stream of information about our own ... in a car the world glides by us and ... effort, our brain calculates self-motion from this "optic flow". This ... gaze during our own movements. Together with biologists from the ...
(Date:4/17/2014)... marrow need to produce hydrogen sulfide in order to ... new study from the Center for Craniofacial Molecular Biology ... , Professor Songtao Shi, principal investigator on the project, ... cells governs the flow of calcium ions. The essential ... in osteogenesis, or the creation of new bone tissue, ...
(Date:4/17/2014)... Singh Thursday as a "Champion of Change" for ... in the residential, commercial and industrial sectors. , ... and Computer Engineering and director of Clemson,s Center ... leading the charge across the country to create ... driving policy changes at the local level to ...
Breaking Biology News(10 mins):How vision makes sure that little fish do not get carried away 2How vision makes sure that little fish do not get carried away 3How vision makes sure that little fish do not get carried away 4White House honors Clemson professor as 'Champion of Change' for solar deployment 2
... China -- Wiley-Blackwell, the scientific, technical, medical and scholarly ... launched a new series of life science pages on ... will make the website a key resource for Chinese ... in publishing their own results in international journals. ...
... and droughts will become more frequent in pace with ... extinction, especially in bio diverse ecosystems such as coral ... flora and fauna become extinct at a rate 100 ... as one of the main causes of species depletion. ...
... proposed study could help determine if there is a link ... and having a higher risk of cancer, but challenges and ... Council, the operating arm of the National Academy of Sciences ... a pilot study be completed first to evaluate the feasibility ...
Cached Biology News:Extreme weather threatens rich ecosystems 2Report presents designs for study of cancer risks near US nuclear facilities 2Report presents designs for study of cancer risks near US nuclear facilities 3
Tris-EDTA Buffer Solution, 1X, pH 8.0, sterile, Molecular Biology Grade...
... Signet offers the most comprehensive, ... requirements. We have incorporated unprecedented quality ... capabilities. This includes proven detection chemistries ... to the TechMate protocol. It also ...
...
Phospho-YAP (Ser127) Antibody Ship: Hot Store: -20 C...
Biology Products: